Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2010234861 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lopez, Omar D.; Chen, Qi; Belema, Makonen; Hamann, Lawrence G.

Agent A J Park

Pub. Number AU-A-2010234861

PCT Pub. Number WO2010/117704

Priority 61/164,579 30.03.09 US

Filing date 29 March 2010

Wipo publication date 14 October 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4184 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 September 2011 PCT application entered the National Phase

  PCT publication WO2010/117704 Priority application(s): WO2010/117704

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234870-Crescent-shaped recess in piston of a split-cycle engine

2010234852-Sealpot and method for controlling a solids flow rate therethrough